4.8 Article

miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts

Journal

CELL
Volume 140, Issue 5, Pages 652-665

Publisher

CELL PRESS
DOI: 10.1016/j.cell.2010.01.007

Keywords

-

Funding

  1. National Cancer Institute [CA095512, CA16058]
  2. NIH, Bethesda, MD, USA
  3. US Army [W81XWH-07-1-0270]
  4. American-Italian Cancer Foundation
  5. Fonds de la Recherche en Sante du Quebec
  6. OSU Graduate School
  7. Leukemia and Lymphoma Society
  8. M.D. Anderson Research Trust
  9. University of Texas System Regents

Ask authors/readers for more resources

MicroRNAs and heterogeneous ribonucleoproteins (hnRNPs) are posttranscriptional gene regulators that bind mRNA in a sequence-specific manner. Here, we report that loss of miR-328 occurs in blast crisis chronic myelogenous leukemia (CML-BC) in a BCR/ABL dose- and kinase-dependent manner through the MAPK-hnRNP E2 pathway. Restoration of miR-328 expression rescues differentiation and impairs survival of leukemic blasts by simultaneously interacting with the translational regulator poly(rC)-binding protein hnRNP E2 and with the mRNA encoding the survival factor PIM1, respectively. The interaction with hnRNP E2 is independent of the microRNA's seed sequence and it leads to release of CEBPA mRNA from hnRNP E2-mediated translational inhibition. Altogether, these data reveal the dual ability of a microRNA to control cell fate both through base pairing with mRNA targets and through a decoy activity that interferes with the function of regulatory proteins.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available